Corporal Michael J. Crescenz VA Medical Center
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Corporal Michael J. Crescenz VA Medical Center sits in the top decile of US sponsors by registered trial count (#1,049 of 15,742 sponsors by registered trial count).
Corporal Michael J. Crescenz VA Medical Center: 13 sponsored US clinical trials, 1 recruiting.
Corporal Michael J. Crescenz VA Medical Center sponsors 13 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 10 completed. 2 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Parkinsonism, with 1 trials.
Top-decile sponsor footprint
Corporal Michael J. Crescenz VA Medical Center ranks in the top decile of sponsors by registered trial count (#1,049 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
10 of 11 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.9%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
13 total, page 1 of 1
Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates
NCT03495024
Pilot Deprescribing of Antimuscarinic Overactive Bladder Medications in Parkinson Disease
NCT07627529
Developing Personalized Medicine Strategies to Increase Physical Activity in Parkinson's Disease (PD) Through Digital Health Technology
NCT05529121
Telemedici ne Management of Veterans With Newly Diagnosed Obstructiv e Sleep Apnea (OSA)
NCT02159885
Using Feedback Reports to Improve Medication Adherence
NCT02480530
Study of Default Options in Advance Directives
NCT01817686
Effect of Inorganic Nitrates (Beetroot Juice) on Arterial Hemodynamics and Exercise Capacity
NCT01919177
The Effect of Family History on Insomnia During Sobriety in Alcoholics
NCT01603381
Improving Fecal Occult Blood Test Completion Rates Among Veterans
NCT01516489
Vasodilator Therapy for Heart Failure and Preserved Ejection Fraction
NCT01516346
Evaluation of the Veterans' In-home Program
NCT01831830
Engaging Caregivers in Dementia Care
NCT02552563
Non-Invasive Prediction of Colorectal Neoplasia
NCT01815463
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 2 |
| Phase 4 | 2 |
Therapeutic Areas
What is open in the Corporal Michael J. Crescenz VA Medical Center pipeline
1 recruiting of 13 indexed (8% open); 10 completed (77%).
Phase mix: 2 late (III/IV) vs 3 early (I/II) (balanced across stages).
Top condition: Parkinsonism (1 trial), 6 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Corporal Michael J. Crescenz VA Medical Center: open-pipeline peers nationwide
Peers matched on 13 registered trials and 8% open enrollment, not the therapeutic-area sidebar.
Corporal Michael J. Crescenz VA Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 13 trials (± recruiting share)
- Adaptimmune · 13 trials · 0% recruiting
- Agennix · 13 trials · 0% recruiting
- Akili Interactive Labs · 13 trials · 0% recruiting
- Alumis · 13 trials · 8% recruiting
Sponsors near 8% open enrollment (± trial volume)
- Andrei Iagaru · 8% recruiting · 13 trials
- BioXcel Therapeutics · 8% recruiting · 13 trials
- Fresenius Medical Care North America · 8% recruiting · 13 trials
- LG Chem · 8% recruiting · 13 trials
Related
What to do with this Corporal Michael J. Crescenz VA Medical Center page
13 registered trials is a research-attention snapshot, not an endorsement of Corporal Michael J. Crescenz VA Medical Center or any single study.
- 1 of Corporal Michael J. Crescenz VA Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Parkinsonism is the condition Corporal Michael J. Crescenz VA Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Parkinsonism trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Corporal Michael J. Crescenz VA Medical Center pipeline card: 13 registered trials from official public datasets.Report a data error.